Clinical Trial

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

Study acronym: EXCEL
Recruiting
View on ClinicalTrials.gov →
Summary
EXCEL will provide online and, where feasible, in-person exercise programs to individuals living with and beyond cancer (ILWBC). Research has shown that targeted programs that include tailored exercise prescriptions are more successful in helping individuals with chronic disease to incorporate physical activity and exercise into their daily routines. While ILWBC are advised by healthcare professionals (HCPs) to engage in exercise, there is a lack of cancer-specific exercise programs and cancer-trained exercise specialists in Canada, outside of the research setting. Considering the negative impact cancer and its treatments have on fitness and physical activity levels, community-based efforts towards improving access, uptake and maintenance of exercise programming are needed. This study will evaluate the benefits of a community-based or online EXCEL exercise program for people living with and beyond cancer across Canada, using a streamlined intake process compared to the original EXCEL Study (HREBA.CC-20-0098, NCT04478851). This 8 to 12-week program (intervention) will be delivered in-person or over virtual platform. It includes twice weekly supervised exercise classes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-28.
Trial Details
NCT Number NCT06960291
Lead Sponsor University of Calgary
Collaborators: University of Alberta, Dalhousie University, Nova Scotia Health Authority, University of Toronto, Centre hospitalier de l'Université de Montréal (CHUM), University of British Columbia, Memorial University of Newfoundland, University of Prince Edward Island, Alberta Health services
Conditions Cancer, Prostate Cancers, Breast Cancers, Colon Cancer, Lung Cancers
Enrollment 740 participants
Start Date 2025-03-11
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-07